USE CASES
NHS Trust Sponsor Research Into Inherited Heart Conditions
•
•
•
Holter Monitoring
A leading University NHS Foundation Trust, based in the UK, is the study sponsor for a multi-site randomized 1-year evaluation of a pharmaceutical treatment for patients with cardiomyopathy.
Problem
A major clinical pharmaceutical trial investigating changes of exercise capacity, heart function and abnormal heart rhythm in patients with cardiomyopathy wanted to incorporate a low-cost clinical-grade ECG heart monitor for over 170 subjects to wear at the initiation and completion of the 12-month hereditary heart disease trial. Traditional holter tests proved to be expensive and inconvenient for patients both for fitting and returning the equipment.
Impact
With the UbiqVue Holter At Home workflow, participants were able to self-apply the wearable biosensor and would return it to the research center after a 24-hour wear period.
- Affordable method to incorporate ECG data into a clinical study without the need of purchasing holter equipment or employing cardiac technicians
- Data can be easily uploaded to the Holter Connect platform for analysis
- Full holter report produced by third-party cardiac technicians
- Eliminates the need for participants to return the holter equipment at the start and end of the assessment
